• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

渗透压反应增强子结合蛋白(活化T细胞核因子5)对人细胞色素P450 3A的渗透压敏感转录调控的发现。

Discovery of osmosensitive transcriptional regulation of human cytochrome P450 3As by the tonicity-responsive enhancer binding protein (nuclear factor of activated T cells 5).

作者信息

Kosuge Kazuhiro, Chuang Andrew I, Uematsu Satoko, Tan Kah Poh, Ohashi Kyoichi, Ko Ben C B, Ito Shinya

机构信息

Division of Clinical Pharmacology and Toxicology, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada.

出版信息

Mol Pharmacol. 2007 Oct;72(4):826-37. doi: 10.1124/mol.107.034504. Epub 2007 Jun 28.

DOI:10.1124/mol.107.034504
PMID:17600221
Abstract

We report the discovery of an osmosensitive transcriptional control of human CYP3A4, CYP3A7, and CYP3A5. Ambient hypertonicity (350-450 mOsmol/kg) increased mRNA expressions of the CYP3A by approximately 10- to 20-fold in human-intestinal C(2)bbe1 cells, followed by an increase of CYP3A protein. Hypotonicity, on the other hand, suppressed CYP3A mRNA levels, indicating that physiological isotonic conditions may regulate the basal expression of CYP3A. Similar responses to ambient tonicity were observed in other human-derived cell lines (intestinal LS180 and hepatic HepG2) and human primary colonic cells. The 11-base pair tonicity-responsive enhancer (TonE) is an osmosensitive regulator that is activated by the transcription factor, the nuclear factor of activated T-cells 5 (NFAT5). Luciferase-based reporter assays of 13 consensus TonE motifs within +/-10 kilobases (kb) from the transcription start sites of CYP3A showed that only the CYP3A7 intron 2 region ( approximately 5 kb downstream from the transcription start site), which contains two TonE motifs (+5076/+5086 and + 5417/+5427), was responsive to hypertonicity stimuli. This observation was confirmed upon cotransfection with an NFAT5 expression vector, small interfering RNA, or dominant-negative NFAT5. Deletion and mutation analyses suggested that the TonE (+5417/+5427) is indispensable for the enhancer activity. NFAT5 binding to the CYP3A7 intron 2 TonE motif was demonstrated with electrophoretic mobility shift assay and in a native cell context by chromatin immunoprecipitation. We conclude that transcription of human CYP3A is influenced by ambient tonicity. The physiological significance of the tonic regulation of CYP3A enzymes remains to be determined.

摘要

我们报告了人类CYP3A4、CYP3A7和CYP3A5存在渗透压敏感转录调控的发现。环境高渗(350 - 450毫摩尔/千克)使人类肠道C(2)bbe1细胞中CYP3A的mRNA表达增加约10至20倍,随后CYP3A蛋白增加。另一方面,低渗抑制了CYP3A mRNA水平,表明生理等渗条件可能调节CYP3A的基础表达。在其他人类来源的细胞系(肠道LS180和肝脏HepG2)以及人类原代结肠细胞中观察到了对环境渗透压的类似反应。11个碱基对的渗透压反应增强子(TonE)是一种渗透压敏感调节因子,由转录因子活化T细胞的核因子5(NFAT5)激活。对CYP3A转录起始位点上下游10千碱基(kb)内的13个共有TonE基序进行基于荧光素酶的报告基因分析表明,只有CYP3A7内含子2区域(转录起始位点下游约5 kb)含有两个TonE基序(+5076 / +5086和+5417 / +5427)对高渗刺激有反应。在用NFAT5表达载体、小干扰RNA或显性负性NFAT-S进行共转染后,这一观察结果得到了证实。缺失和突变分析表明,TonE(+5417 / +5427)对于增强子活性是不可或缺的。通过电泳迁移率变动分析以及在天然细胞环境中通过染色质免疫沉淀证明了NFAT5与CYP3A7内含子2 TonE基序的结合。我们得出结论,人类CYP3A的转录受环境渗透压影响。CYP3A酶渗透压调节的生理意义仍有待确定。

相似文献

1
Discovery of osmosensitive transcriptional regulation of human cytochrome P450 3As by the tonicity-responsive enhancer binding protein (nuclear factor of activated T cells 5).渗透压反应增强子结合蛋白(活化T细胞核因子5)对人细胞色素P450 3A的渗透压敏感转录调控的发现。
Mol Pharmacol. 2007 Oct;72(4):826-37. doi: 10.1124/mol.107.034504. Epub 2007 Jun 28.
2
Ambient tonicity and intestinal cytochrome CYP3A.环境渗透压与肠道细胞色素 CYP3A
Expert Opin Drug Metab Toxicol. 2010 Aug;6(8):883-93. doi: 10.1517/17425251003781912.
3
Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element.Sp1和Sp3通过核因子κB样元件对人CYP3A7基因进行新型转录调控。
J Biol Chem. 2001 Oct 12;276(41):38010-22. doi: 10.1074/jbc.M106130200. Epub 2001 Aug 8.
4
Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein).人类肝脏CYP3A4的转录调控:鉴定一个对CCAAT/增强子结合蛋白β异构体(肝脏激活蛋白和肝脏抑制蛋白)有反应的新的远端增强子区域。
Mol Pharmacol. 2005 Jun;67(6):2088-101. doi: 10.1124/mol.104.008169. Epub 2005 Mar 18.
5
Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gamma.CCAAT增强子结合蛋白α和肝细胞核因子-3γ对人CYP3A4基础表达的转录调控
Mol Pharmacol. 2003 May;63(5):1180-9. doi: 10.1124/mol.63.5.1180.
6
Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.人CYP3A5基因中一种新型地塞米松反应性增强子的鉴定及其在人和大鼠肝细胞中的激活
Mol Pharmacol. 1996 Jan;49(1):63-72.
7
The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module.孤儿型人孕烷X受体通过一个远端增强子模块介导利福平对CYP3A4的转录激活作用。
Mol Pharmacol. 1999 Dec;56(6):1329-39. doi: 10.1124/mol.56.6.1329.
8
Genetic contribution to variable human CYP3A-mediated metabolism.人类CYP3A介导的代谢变异性的遗传贡献。
Adv Drug Deliv Rev. 2002 Nov 18;54(10):1271-94. doi: 10.1016/s0169-409x(02)00066-2.
9
Transcription factor binding to a putative double E-box motif represses CYP3A4 expression in human lung cells.转录因子与假定的双E盒基序结合可抑制人肺细胞中CYP3A4的表达。
Mol Pharmacol. 2007 Sep;72(3):514-25. doi: 10.1124/mol.106.033795. Epub 2007 Jun 4.
10
Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers.日本人与高加索人在CYP3A4、CYP3A5和CYP3A7 mRNA表达水平上的种族差异:日本肝脏中CYP3A表达缺乏共同调控。
Xenobiotica. 2005 Jan;35(1):69-83. doi: 10.1080/00498250400021796.

引用本文的文献

1
NFAT5: a stress-related transcription factor with multiple functions in health and disease.NFAT5:一种在健康和疾病中具有多种功能的应激相关转录因子。
Cell Stress. 2025 May 22;9:16-48. doi: 10.15698/cst2025.05.304. eCollection 2025.
2
Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease.用于选择性调节肾脏疾病中 CYP3A5 的反义寡核苷酸的开发。
Sci Rep. 2021 Feb 25;11(1):4722. doi: 10.1038/s41598-021-84194-w.
3
The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan.
饮食钠含量对非马沙坦药代动力学和药效学的影响。
Drug Des Devel Ther. 2016 Apr 19;10:1525-31. doi: 10.2147/DDDT.S94694. eCollection 2016.
4
Exploring the relationship between lifestyles, diets and genetic adaptations in humans.探索人类生活方式、饮食与基因适应性之间的关系。
BMC Genet. 2015 May 28;16:55. doi: 10.1186/s12863-015-0212-1.
5
NFAT5 in cellular adaptation to hypertonic stress - regulations and functional significance.NFAT5在细胞对高渗应激的适应中——调控及其功能意义
J Mol Signal. 2013 Apr 23;8(1):5. doi: 10.1186/1750-2187-8-5.
6
NFAT5-dependent expression of AQP4 in astrocytes.星形胶质细胞中 NFAT5 依赖性 AQP4 的表达。
Cell Mol Neurobiol. 2013 Mar;33(2):223-32. doi: 10.1007/s10571-012-9889-0. Epub 2012 Nov 20.
7
Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.肾脏病理生理学与心血管医学交叉领域的三大药物基因组学与个性化医学应用
Curr Pharmacogenomics Person Med. 2011 Dec;9(4):299-322. doi: 10.2174/187569211798377135.
8
The role of hyperosmotic stress in inflammation and disease.高渗应激在炎症和疾病中的作用。
Biomol Concepts. 2012 Aug;3(4):345-364. doi: 10.1515/bmc-2012-0001.
9
Role of NFAT5 in inflammatory disorders associated with osmotic stress.NFAT5 在与渗透胁迫相关的炎症性疾病中的作用。
Curr Genomics. 2010 Dec;11(8):584-90. doi: 10.2174/138920210793360961.
10
Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.更新药物代谢系统信息——2009 年,第二部分:疾病和环境因素对人细胞色素 P450(CYP)酶和转运体影响的信息摘要。
Curr Drug Metab. 2010 Jan;11(1):4-84. doi: 10.2174/138920010791110917.